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Abstract
Background: Unequal access to health care contributes to disparities in cancer outcomes. We examined the
ethnic disparity in barriers to accessing primary and specialist health care experienced by New Zealand women
with breast cancer.
Methods: Women diagnosed with a primary invasive breast cancer between 2005 and 2007 were eligible. There
were 1,799 respondents, n = 302 Māori (the indigenous population of NZ), n = 70 Pacific and n = 1,427 non-Māori/
non-Pacific women. Participants completed a questionnaire listing 12 barriers grouped into three domains for
analysis: personal; practical; and health care process factors, and reported the number of days between seeing a
primary and a specialist care provider. Chi-squared, Fisher exact tests and logistic regression were used to assess
uni- and multivariable differences in prevalence between ethnic groupings.
Results: The prevalence of reporting three or more barriers was 18 % among Pacific, 10 % among Māori and 3 %
among non-Māori/non-Pacific women (P <0.001). The most commonly reported barriers were fear (Māori women)
and cost (Pacific and non-Māori/non-Pacific women). Ethnic differences in reported barriers were not explained
by deprivation or diabetes prevalence. Women with diabetes reported a two-fold higher risk of experiencing barriers
to care compared to those without diabetes (odds ratio [OR]: 2.06, 95%CI 1.20 to 3.57). Māori and Pacific women were
more likely to face delays (median 14 days) in seeing a specialist than non-Māori/non-Pacific women (median 7 days);
these differences were not explained by the reported barriers.
Conclusions: Patterns of reported barriers to care differed according to ethnicity and were not explained by
deprivation, or presence of co-morbidity. Māori and Pacific women are more likely to experience barriers to
breast cancer care compared to non- Māori/non-Pacific women. We identified two key barriers affecting care
for Māori and Pacific women; (a) delays in follow-up, and (b) the impact of co-morbid conditions. Future New
Zealand work needs to focus attention on health care process factors and improving the interface between
primary and secondary care to ensure quality health care is realised for all women with breast cancer.
Background
Women in New Zealand (NZ) experience high breast
cancer incidence and mortality rates compared to many
other developed countries [1]. The burden of breast can-
cer is high and accounted for nearly 28 % of all cancer
registrations and 16 % of all cancer deaths among NZ
women in 2010 [2]. It is also worse among indigenous
Māori women, who have a 60 % higher incidence of
breast cancer [2] and a lower 4-year relative survival
(86 % vs 92 %) [3] compared to non-Māori women. A
growing body of literature indicates that access to care is
a critical contributing factor to disparities in cancer out-
comes [4, 5] although to date, little work has been done
in NZ specifically in this area [5–7].
The recognised complexity involved in the provision
of cancer services highlights the importance of access
throughout the entire cancer care pathway with differ-
ences in health care access likely to be important media-
tors of cancer survival disparities [5, 8–11]. To guide
our analysis, we developed a conceptual model (Fig. 1),
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in which we view ‘access’ as a multidimensional and
multilevel process encompassing both “access to” and
“access through” health care; the latter concept taking
into account service quality. Access can be broadly con-
sidered across three interacting domains encompassing
(a) health care processes; (b) patient factors; and (c)
structural/health system factors [5, 9]. Examples of
health care processes include availability of appoint-
ments, the effect of co-morbidity on treatment choices
[10–12] or physicians’ perceptions and biases [10, 13,
14]. Patient factors relate to both practical issues that
impact on decision-making such as family support and
financial constraints [5, 9] as well as the influence of
personal factors including fear or embarrassment [15–
17]. Additionally, historical and contemporary structural
health system factors including cultural safety across the
health care spectrum, location and funding of services
and the content of training programmes for health pro-
fessionals are also important determinants of health care
access and quality [5, 10, 11, 18–23].
Our aim was to understand ethnic differences in ac-
cess to care among women with breast cancer in New
Zealand. The specific hypotheses tested were: i) that the
prevalence of barriers to primary and secondary care dif-
fer by ethnicity; ii) that some of these differences may be
explained by deprivation and/or co-morbidity; iii) that
barriers to care may explain some of the ethnic differ-
ences in delay in accessing care and iv) that screening
services, and hence earlier diagnosis, are differentially
used by women of different ethnicities.
Methods
Study population
The ‘New Zealand Breast Cancer Study’, a population-
based case–control study, investigated risk factors through-
out the lifecourse for breast cancer among three ethnic
groupings: Māori, who make up approximately 15 % of the
NZ population; Pacific (a composite group combining
peoples self-identifying as Samoan, Cook Island Māori,
Tongan, Tokelauan, Niuean, Fijian or from ‘other’ Pacific
islands), who comprise 7 % of the population; European
(74 %) (primarily from the United Kingdom and Europe)
and Asian peoples (12 %) including those from South East
Asia, Chinese and India [24, 25]. These last two groups are
hereafter referred to as non-Māori/non-Pacific. Ethnicity
data were collected based on the NZ census self-identified
ethnicity and coded using a prioritized system whereby
people who identify with more than one ethnic group are
assigned to a single mutually exclusive category based on
an established (Māori, Pacific, non-Māori/non-Pacific)
hierarchy [26]. Thus, anyone identifying as Māori is coded
as Māori regardless of any other ethnic group that person
may have recorded; anyone identifying with a Pacific Island
ethnic group was coded as Pacific unless they also identi-
fied as Māori and those coded as non-Māori/non-Pacific
will not have identified as having either Māori or Pacific
ethnicity.
The study design and methods have been published
previously [27]. Eligibility was defined as having a
primary invasive breast cancer registered on the NZ
Cancer Registry (NZCR) between 1 April 2005 and 30
April 2006. Over-sampling of Māori and Pacific women
involved inviting women diagnosed with breast cancer
for a further 12 months (to 30th April 2007) to ensure
sufficient statistical power for ethnic-specific analyses.
The response rate was 78 % in non-Māori/non-Pacific
women (n = 1,427), 46 % in Pacific women (n = 70), and
81 % in Māori women (n = 302). Written consent was
obtained from all participants and ethical approval was
granted by the Central Health and Disability Ethics
Committee (WGT/03/12/126) of NZ. In this study,














Fig. 1 Conceptual model of access to cancer care. * Barriers: (1) Personal: embarrassment, not wanting to make a fuss, preferring not to know
(fear), feeling it is pointless (2) Practical: cost, no transport, lack of childcare, can’t spare time/other priorities, pain (3) Health care process: not being
able to get an appointment soon enough, not able to get in touch with the doctor, not trusting the health professional (Note: the dashed lines and
box [Survival] are included for completeness, but have not been assessed in this analysis)
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Data collection and assessment of barriers to care
Participants completed a detailed questionnaire socio-
demographics, health behaviours, anthropometry, re-
productive history, occupational history; and access to
primary care and breast cancer treatment services [27]
with most (89 %) questionnaires self-completed in English
and returned by post. Other modalities for Māori and
Pacific women included translation (<1 % of participants),
telephone (8.6 %), or a face-to-face interview (1.8 %).
An area-based measure, the NZ Deprivation Index 2006
[28], assessed level of deprivation, using variables derived
from the 2006 census, based on place of residence at the
time of diagnosis, and was analysed in quintiles.
The list of barriers included in the questionnaire, fo-
cused on health care process and patient factors (divided
into practical and personal factors), and was generated by
the authors through a literature review, and tested in the
pilot phase of the study [27]. A response option of “Other’
was also included where women could write in any add-
itional barriers experienced which were not included on
the list. To investigate the role of co-morbidity in deter-
mining barriers to care, we used a self-reported measure
of doctor-diagnosed diabetes (Have you ever been told by
a doctor that you have diabetes or sugar in the blood’ –
Yes/No). This measure was chosen, as diabetes prevalence
in NZ is strongly patterned by ethnicity [29] and we had
little data on additional co-morbidities.
To further understand the role of access to screening
among women with breast cancer, we performed an
analysis of tumour size and stage according to age. All
women in NZ aged 45–69 years are eligible for free
mammography through Breast Screen Aotearoa, the
national screening programme [30]. We therefore cate-
gorized women according to eligibility for free mammog-
raphy, and examined proportions of women diagnosed at
an early stage, by ethnic grouping. Because of substantial
missing data on stage at diagnosis, tumour size was also
evaluated.
Statistical methods
The potential barriers studied were tabulated individu-
ally. Chi-squared tests were used to test for differences
in frequency, by ethnic grouping. In instances where one
or more cells had fewer than five observations, exact
tests were used in place of chi-squared tests. Although
we purposely oversampled Māori and Pacific women, as
all measures of prevalence were stratified by ethnicity,
we did not need to account for sampling fractions in the
analysis.
Given the sparse data, subsequent logistic regression
was used to estimate odds ratios (OR) with 95 % confi-
dence intervals (CI) for the association between ethnicity
and each of the three barrier domain groupings, rather
than for individual barriers. These OR were adjusted for
age (continuous variable), then for age and deprivation
quintile (categorical variable). The weeks and days be-
tween seeing a primary care provider and a specialist were
converted to days. Non-parametric Kruskal Wallis tests
were used to test for differences in median number of
days’ delay between ethnic groupings, given the skewed
nature of the data.
Results
Demographic and clinical characteristics of participants
are shown in Table 1. Māori and Pacific women were
younger, came from more deprived areas, had larger /
more advanced tumours and were more likely to have
diabetes than non-Māori/non-Pacific women.
Barriers to primary care
Barriers faced by women attending a primary care pro-
vider are shown in Table 2. Overall, non-Māori/non-Pa-
cific women reported the fewest barriers, and among
women reporting more than 3 barriers, the proportion
was highest among the Pacific women (18 %), followed
by the Māori women (10 %), and lowest among the non-
Māori/non-Pacific women (3 %) (P <0.001). Among the
Pacific women, the most commonly reported barriers
were cost, inability to get a suitably timed appointment,
fear, and not trusting a health professional. For Māori
women, the most commonly reported barriers were fear,
cost, and not wanting to make a fuss. For non-Māori/
non-Pacific women, the most common barriers were cost
and not wanting to make a fuss. ‘Other’ primarily included
text which expanded on those barriers already listed. The
most common additional comment made by women was
in regard to delay in being followed up (Māori n = 3;
Pacific n = 2; non-Māori/non-Pacific n = 12). Lack of
cultural support was noted by one Māori participant.
Barriers to cancer specialist care
Barriers faced by women in seeing a specialist are shown in
Table 3. Among Pacific women, 13 % reported facing three
or more barriers, compared to 7 % among Māori women
and 3 % non-Māori/non-Pacific women (P <0.001). Com-
pared to barriers reported for the primary care provider,
for specialist care, cost and inability to get a timely ap-
pointment were reported more frequently by all ethnic
groupings. For Māori and non-Māori/non-Pacific women,
the remainder of the barriers were reported at a similar
frequency to the primary care provider analysis, whereas
for Pacific women, these were reported less frequently.
Specific issues reported more often by Māori compared to
other women were not being able to spare the time and
not having transport. Both Māori and Pacific women re-
ported preferring not to know / fear of being unwell and
concerns about pain as barriers to seeking care.
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Co-morbidity and access to care
The prevalence of diabetes was 8 % in non-Māori/non-
Pacific women, 19 % in Māori and 17 % in Pacific women
(P <0.001). Having diabetes was not related to reported
barriers across any of the three domain groupings, for
either a GP or specialist, except for practical barriers in
seeing a GP. Women with diabetes reported an over
two-fold higher risk of facing such barriers compared
to those without diabetes (age- and ethnicity-adjusted
OR: 2.06, 95%CI 1.20 to 3.57). When stratified by ethni-
city, it did not appear that the effect of having a co-
morbidity on reported barriers to care differed by ethnic
grouping, P (interaction) = 0.18.
Ethnic differences in accessing cancer care
Table 4 shows the multivariable analysis of the associa-
tions between ethnicity and the three barrier domains.
Māori and Pacific women were more likely than non-
Māori/non-Pacific women to report barriers in all three
domains, with the strongest associations being for Pacific
women facing health care process barriers in seeing a GP.
None of the associations were explained by deprivation or
by having a co-morbidity.
Delay in access to care
The median delay between seeing a primary and specialist
care provider was 14 days (inter-quartile range [IQR] -7 to
18) for Māori women, 14 days (IQR −7 to 21) for Pacific
women and 7 days (IQR −3 to 14) for non-Māori/non-Pa-
cific women, P <0.001. Thus, at 14 days after seeing a
primary care provider, three-quarters of non-Māori/non-
Pacific women had seen a specialist, compared with half
of Māori and Pacific women. Age-adjusted analyses show
that Māori and Pacific women are more likely to wait over
7 days between seeing a primary and secondary care
provider than non-Māori/non-Pacific women (Table 5).




N (%) N (%) N (%)
Total 302 (100) 70 (100) 1427 (100)
Age (years)
20–35 10 (3.3) 4 (5.7) 25 (1.8)
36–50 97 (32.1) 37 (52.9) 377 (26.4)
51–65 137 (45.4) 19 (27.1) 589 (41.3)
>65 58 (19.2) 10 (14.3) 436 (30.6)
NZDep (quintiles)
Q1 (least deprived) 16 (5.3) 5 (7.1) 282 (19.8)
Q2 31 (10.3) 5 (7.1) 265 (18.6)
Q3 52 (17.2) 9 (12.9) 333 (23.4)
Q4 73 (24.2) 21 (30.0) 325 (22.8)
Q5 (most deprived) 130 (43.1) 30 (42.9) 218 (15.3)
Extent
Local 136 (52.5) 28 (52.8) 712 (56.7)
Regional 116 (44.8) 23 (43.4) 528 (42.0)
Distant 7 (2.7) 2 (3.8) 16 (1.3)
Tumour size (mm)
<10 mm 34 (12.8) 9 (15.8) 308 (23.6)
11–19 69 (25.9) 16 (28.1) 416 (31.9)
20–29 105 (39.5) 13 (22.8) 325 (24.9)
30+ 58 (21.8) 19 (33.3) 255 (19.6)
Diabetes
Yes 58 (19.2) 12 (17.1) 115 (8.1)
No 244 (80.8) 58 (82.9) 1,309 (91.9)
Eligible for free screeninga
% never screened 5 % 5 % 12 %
% tumours < 10 mm
(p <0.001)
14 % 20 % 26 %
% localized stage
(p <0.001)
47 % 40 % 53 %
awomen aged 45–69 years only
Table 2 Distribution of reported barriers to primary care by




Cost 15 (5 %) 8 (11 %) 41 (3 %) <0.001
Couldn’t get an
appointment soon enough
or at a suitable time
10 (3 %) 7 (10 %) 21 (1 %) <0.001
Couldn’t spare the time /
other priorities
8 (3 %) 1 (1 %) 29 (2 %) 0.79
Didn’t want to make a
fuss
13 (4 %) 3 (4 %) 38 (3 %) 0.19
Had no transport to get
there
4 (1 %) 3 (4 %) 9 (<1 %) 0.012
Couldn’t get in touch with
the doctor or other
professional
3 (1 %) 1 (1 %) 6 (<1 %) 0.12
Lack of childcare 2 (<1 %) 3 (4 %) 9 (<1 %) 0.023
Embarrassment 6 (2 %) 3 (4 %) 14 (1 %) 0.031
Pain or discomfort 7 (2 %) 3 (4 %) 8 (<1 %) 0.001
Prefer not to know
condition / fear of
being unwell
21 (7 %) 7 (10 %) 29 (2 %) <0.001
Do not trust health
professional
9 (3 %) 6 (9 %) 9 (<1 %) <0.001
Feel that it is pointless 3 (1 %) 3 (4 %) 4 (<1 %) 0.002
Other 18 (6 %) 7 (10 %) 36 (3 %) <0.001
The table shows the number of women who reported each item as a barrier;
totals therefore sum to larger than the number of participants, as each woman
could record more than one. P values derive from chi-squared tests, comparing
proportions across the three ethnic groupings. In instances where there were
five or fewer women in a particular cell, the P value reported is from a Fisher
exact test
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However, these ethnic differences in delays were not ex-
plained by the barriers which Māori and Pacific women
reported facing when seeing a specialist.
Access to screening services
We explored the relationship between ethnicity and ex-
tent of disease at diagnosis, among women in the 45–
69 year age range who were eligible for mammographic
screening. Five percent of Māori and non-Māori/non-
Pacific women and 12 % of Pacific women reported
never having been screened. Tumour size differed be-
tween ethnic grouping, with 14 % of Māori, 20 % of Pa-
cific and 26 % of non-Māori/non-Pacific women having
a tumour of under 10 mm (P <0.001). The proportion of
cancers which were diagnosed at a localised stage were
53 % for non-Māori/non-Pacific women, 47 % for Māori
and 40 % for Pacific women (P <0.001). In addition, sta-
ging data were missing for a further 33 % of Pacific
women, presumably because the cancer had spread so
far that surgery was not indicated. There was no associ-
ation between stage of disease or tumour size and dia-
betes in any ethnic grouping.
Discussion
To our knowledge, this is the largest study of barriers to
care among women with breast cancer in NZ. Key find-
ings were that Māori and Pacific women were more
likely to report multiple barriers to accessing primary
care compared to non-Māori/non-Pacific women, and
that these differences were not explained by deprivation.
The longer delays for Māori and Pacific women for see-
ing a specialist were likewise not explained by any of the
reported barriers to seeing a specialist. Additionally,
although there was no ethnic difference in the greater
barriers experienced by women with versus without dia-
betes, the prevalence of diabetes was highest among the
Māori and Pacific women. The implication is that deter-
minants of barriers to care by ethnicity involve more
than deprivation and are affected by co-morbidity.
The study had three main limitations. Firstly, all the
data were self-reported. For some measures of barriers,
this is appropriate, but we would like to have had other
measures relating to, for example, screening. The re-
ported levels of ‘never screened’ in the current study
were very low compared with those reported by the NZ
breast screening programme, for example, biennial
screening rates for women in 2009–2010 for the 50–69
years age group was 70.1 % with significantly lower par-
ticipation evident for the eligible Māori and Pacific
populations (58.1 and 64.3 % respectively) [31]. We are
therefore unsure of the validity of our figures for self-
reported screening participation; it may be that informa-
tion given to women about the reason for mammography
is not sufficiently clear and that the distinction between
screening and symptomatic presentation, which is often
investigated with mammography, needs to be more fully
explained.
A second limitation was that much of the data was col-
lected several months after diagnosis. This was due to the
ethics committee request that we not contact participants
within eight months of being diagnosed, to minimise dis-
tress. Thus, the reported experiences of women could
have changed in response to the disease outcome and
treatment in the months following diagnosis. We also ac-
knowledge that although we had a free text option there
may have been other barriers experienced by women that
were not covered by our questionnaire, for example, relat-
ing to experiences of ethnic discrimination.
Thirdly, the response rate for Pacific women was low.
There were small numbers in some categories which af-
fected the precision of the percentages and effect esti-
mates; we used appropriate statistical methods for
small sample sizes. Given the paucity of research con-
ducted in this population group however, we think this
study makes an important contribution in terms of in-
creasing the limited evidence available regarding the
experience of breast cancer in Pacific women.
Table 3 Distribution of reported barriers to seeing a cancer





Cost 21 (7 %) 12 (17 %) 75 (5 %) <0.001
Couldn’t get an
appointment soon enough
or at a suitable time
21 (7 %) 10 (14 %) 91 (7 %) 0.037
Couldn’t spare the time /
other priorities
5 (2 %) 1 (1 %) 4 (<1 %) 0.012
Didn’t want to make a fuss 8 (3 %) 1 (1 %) 17 (1 %) 0.16
Had no transport to get
there
8 (3 %) 1 (1 %) 4 (<1 %) <0.001
Couldn’t get in touch with
the doctor or other
professional
4 (1 %) 2 (3 %) 12 (1 %) 0.16
Lack of childcare 2 (1 %) 1 (1 %) 7 (1 %) 0.29
Embarrassment 6 (2 %) 1 (1 %) 9 (1 %) 0.056
Pain or discomfort 6 (2 %) 2 (3 %) 3 (<1 %) <0.001
Prefer not to know
condition / fear of
being unwell
14 (5 %) 4 (6 %) 16 (1 %) <0.001
Do not trust health
professional
7 (2 %) 4 (6 %) 7 (1 %) <0.001
Feel that it is pointless 3 (1 %) 1 (1 %) 3 (<1 %) 0.045
Other 13 (4 %) 2 (3 %) 56 (4 %) 0.88
The table shows the number of women who reported each item as a barrier;
totals therefore sum to larger than the number of participants, as each woman
could record more than one. P values derive from chi-squared tests, comparing
proportions across the three ethnic groupings. In instances where there were five
or fewer women in a particular cell, the P value reported is from a Fisher
exact test
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Our findings are consistent with other literature on eth-
nic barriers to care in NZ. Income, education, housing
and employment are well recognized as key determinants
of health [5, 10, 18, 31]. The differential distribution of
deprivation, living standards, occupation and employment
status by ethnicity in NZ have ongoing consequences in
terms of access to care and health outcomes [29, 32]. For
example, the 2011/2012 NZ Health Survey of over 17,000
adults found that approximately 14 % had deferred visiting
a GP in the previous year because of cost, with Māori,
Pacific and low income groups experiencing the greatest
levels of unmet need in the primary care area compared
to other population groups [29]. These are much higher
proportions than identified in the current study however,
possibly because the survey data included mostly healthy
participants whereas the majority of women with symp-
tomatic breast cancer probably realised that they had a
potentially serious health problem. In terms of personal
barriers, Pacific and Māori women were more likely than
their non-Māori/non-Pacific counterparts to report fear as
a barrier to seeking care in the current study. High anxiety
levels have been documented amongst women attending
routine mammography screening, with Māori and Pacific
women more likely to report feeling ‘very worried’ about
breast cancer compared to NZ European and Asian
women [17].
Tumour size and stage may be considered as proxy
measures of health care access since these factors could,
in many instances, be mitigated by earlier presentation
and diagnosis.
We found ethnic differences in delays for referral to
specialist care follow-up which have been reported in
previous work [31, 33] along with a greater likelihood of
larger tumours and later stage among Māori and Pacific
compared to non-Māori/non-Pacific women which has
also been documented [3]. With regard to comorbidity,
even though the ethnic disparities in prevalence were as
expected, for each ethnic grouping, the actual prevalence
rate was higher than recently reported figures [29]. It
can be argued that co-morbidity should improve the
likelihood of early cancer detection, in that those with a
co-morbid condition have more frequent and/or regular
Table 4 Multivariable associations between ethnicity and barriers to accessing care, among women in New Zealand with breast cancer
Model 1 Model 2 Model 3
Māori women
Primary care
Personal barriers 2.06 (1.28 to 3.29) 2.06 (1.25 to 3.41) 2.15 (1.33 to 3.46)
Practical barriers 1.56 (0.99 to 2.47) 1.39 (0.85 to 2.26) 1.46 (0.92 to 2.33)
Health care process barriers 2.67 (1.48 to 4.79) 2.35 (1.25 to 4.41) 2.57 (1.41 to 4.66)
Specialist care
Personal barriers 2.97 (1.68 to 5.22) 2.57 (1.40 to 4.71) 2.91 (1.63 to 5.18)
Practical barriers 1.64 (1.06 to 2.51) 1.60 (1.01 to 2.52) 1.60 (1.04 to 2.47)
Health care process barriers 1.17 (0.76 to 1.84) 1.10 (0.69 to 1.76) 1.15 (0.73 to 1.81)
Pacific women
Primary care
Personal barriers 2.28 (1.03 to 5.05) 2.49 (1.09 to 5.70) 2.30 (1.03 to 5.13)
Practical barriers 2.42 (1.20 to 4.87) 2.12 (1.02 to 4.40) 2.19 (1.07 to 4.46)
Health care process barriers 7.59 (3.65 to 15.81) 6.49 (2.98 to 14.15) 7.41 (3.52 to 15.58)
Specialist care
Personal barriers 3.33 (1.32 to 8.40) 3.57 (1.36 to 9.42) 3.37 (1.33 to 8.58)
Practical barriers 2.75 (1.44 to 5.24) 2.78 (1.42 to 5.47) 2.68 (1.39 to 5.14)
Health care process barriers 2.26 (1.18 to 4.34) 2.16 (1.10 to 4.25) 2.29 (1.19 to 4.41)
Model 1: age adjusted; Model 2: age and deprivation adjusted; Model 3: age and co-morbidity adjusted
The reference group is non-Māori/non-Pacific, so all OR compare Māori or Pacific women to the non-Māori/non-Pacific grouping
Table 5 Multivariable associations between ethnicity and delay
of over one week in seeing a specialist, among women in New
Zealand with breast cancer
Māori Pacific
Specialist care
Age-adjusted 1.30 (1.00 to 1.69) 1.57 (0.91 to 2.73)
+Personal barriers 1.30 (1.00 to 1.68) 1.57 (0.90 to 2.72)
+Practical barriers 1.29 (0.99 to 1.67) 1.52 (0.87 to 2.64)
+Health care process barriers 1.27 (0.98 to 1.66) 1.42 (0.81 to 2.50)
+All barriers 1.28 (0.98 to 1.67) 1.45 (0.82 to 2.55)
The reference group is non-Māori/non-Pacific, so all OR compare Māori or Pacific
women to the non-Māori/non-Pacific grouping
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engagement with health services than those without co-
morbidity [34]. However, in our study, diabetes was not
associated with either tumour stage or size, suggesting
that engagement with the health care system for a comor-
bid condition does not automatically lead to better cancer
health care.
Our results point to a need for new research to deter-
mine what factors cause – and also can reduce – ethnic
disparities in access to appropriate care, both apart from
and in conjunction with, deprivation and comorbidity.
For example, a few NZ studies have identified integra-
tion of primary and secondary care and enhancement of
mainstream services as being important enablers for
successfully negotiating the complex cancer services en-
vironment [6, 7]. Campbell et al. [8] note that nearly all
the priorities for cancer services are affected by actions
in primary care – reducing the risk of cancer, early
detection, faster access to specialist treatment and, plan-
ning to ensure adequate follow-up support post treatment.
The NZ Ministry of Health is currently investigating ways
to improve the quality, timeliness and options for different
treatment service models for patients along the whole
cancer pathway [35, 36]. Other avenues of intervention
might be to expand support and resources to ensure the
proactive engagement of health providers with the com-
munities they serve, since evidence indicates this type of
approach has enabled NZ screening programmes to suc-
cessfully increase participation rates [37, 38]. Although we
were unable to examine the explicit role of structural
factors in these analyses, their interaction and influence
on health care process and individual level factors, as crit-
ical determinants of access to care, are well documented
[5, 9–12, 18–20, 39–42]. Factors such as health provider
biases and institutional racism have been found to be im-
portant determinants of access to care in NZ and overseas
[10, 13, 14, 20] both with regard to the potential impact
on stage at which patients present with their symptoms as
well as issues of trust in health professionals as was
highlighted particularly for Pacific women in this study.
Other factors including centralisation of services, while
practical, may also exacerbate inequalities in access where,
for example, remoteness to treatment centres [22] are
likely to have a differential impact on population groups
with fewer resources to offset the often significant eco-
nomic [40] and social costs [41, 42] of cancer care.
Conclusions
We have identified ethnic differences in the prevalence
and patterns of barriers to health care services that NZ
women face. Māori and Pacific women more likely to ex-
perience barriers to breast cancer care compared to non-
Māori/non-Pacific women with two key barriers affecting
care identified: (a) delays in follow-up, and (b) the impact
of co-morbid conditions. From these data, it is premature
to make direct recommendations for practice. However,
health care process factors relating to the interface
between primary and secondary care services may be
important considerations in terms of both delays in
follow-up for Māori and Pacific women and the impact
of co-morbid conditions on health care provision and
outcomes. Future NZ work needs to focus attention on
health care process factors and improving the interface
between primary and secondary care to ensure quality
health care is realised for all women with breast cancer.
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